| # | Drug | Count |
|---|---|---|
| 0 | IBUPROFEN | 95 |
| 1 | IBUPROFEN SODIUM | 83 |
| 2 | IBUPROFEN TABLETS, COATED | 83 |
| 3 | ICOSAPENT ETHYL | 49 |
| 4 | LEVOTHYROXINE SODIUM | 43 |
| 5 | METFORMIN | 34 |
| 6 | METFORMIN ER 500 MG | 34 |
| 7 | METFORMIN ER 750 MG | 34 |
| 8 | LISINOPRIL | 33 |
| 9 | NAPROXEN SODIUM | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ICOSAPENT ETHYL | 49 | 0.0056 |
| 1 | IBUPROFEN SODIUM | 83 | 0.0019 |
| 2 | RIPRETINIB | 10 | 0.0019 |
| 3 | ETRAVIRINE | 7 | 0.0016 |
| 4 | CEFUROXIME AXETIL | 5 | 0.0014 |
| 5 | COLESTIPOL HYDROCHLORIDE | 3 | 0.0011 |
| 6 | QUINAPRIL HYDROCHLORIDE | 5 | 0.0006 |
| 7 | LORATADINE AND PSEUDOEPHEDRINE SULFATE | 3 | 0.0004 |
| 8 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 8 | 0.0004 |
| 9 | LOPERAMIDE HYDROCHLORIDE | 16 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 146 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 39 |
| 2 | Benzodiazepine [EPC] | 36 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 30 |
| 4 | Proton Pump Inhibitor [EPC] | 29 |
| 5 | Provitamin D2 Compound [EPC] | 27 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 24 |
| 7 | Factor Xa Inhibitor [EPC] | 24 |
| 8 | Anti-epileptic Agent [EPC] | 22 |
| 9 | Calcium Channel Blocker [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 1 | Provitamin D2 Compound [EPC] | 27 | 0.0009 |
| 2 | Photoenhancer [EPC] | 3 | 0.0008 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0004 |
| 5 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 7 | Cannabinoid [EPC] | 2 | 0.0002 |
| 8 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Bismuth [EPC] | 1 | 0.0002 |